{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:59:18Z","timestamp":1792083558455,"version":"4.4.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004028","name":"Jiangnan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004028","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2027,2]]},"DOI":"10.1016\/j.bmcl.2026.130792","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:05:44Z","timestamp":1791561944000},"page":"130792","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design, synthesis, and biological evaluation of 4H-pyran-4-one-based CYP11A1 inhibitors"],"prefix":"10.1016","volume":"143","author":[{"given":"Jingyi","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yipeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizheng","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bmcl.2026.130792_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.bmcl.2026.130792_bb0010","doi-asserted-by":"crossref","unstructured":"Attard G, Parker C, Eeles RA, et al. Prostate cancer. Lancet 2016\/01\/02 2016;387(10013):70\u201382. doi:https:\/\/doi.org\/10.1016\/S0140-6736(14)61947-4.","DOI":"10.1016\/S0140-6736(14)61947-4"},{"key":"10.1016\/j.bmcl.2026.130792_bb0015","doi-asserted-by":"crossref","unstructured":"Feng Q, He B. Androgen receptor signaling in the development of castration resistant prostate cancer. Front Oncol 2019\/09\/04; 9:858. doi:https:\/\/doi.org\/10.3389\/fonc.2019.00858.","DOI":"10.3389\/fonc.2019.00858"},{"key":"10.1016\/j.bmcl.2026.130792_bb0020","doi-asserted-by":"crossref","unstructured":"Zhou J, Wang Y, Wu D, et al. Orphan nuclear receptors as regulators of intratumoral androgen biosynthesis in castration resistant prostate cancer. Oncogene 2021\/04\/01; 40(15):2628-2634. doi:https:\/\/doi.org\/10.1038\/s41388-021-01737-1.","DOI":"10.1038\/s41388-021-01737-1"},{"key":"10.1016\/j.bmcl.2026.130792_bb0025","doi-asserted-by":"crossref","unstructured":"Miller WL, Auchus RJ. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev 2011\/02\/01; 32(1):81-151. doi:https:\/\/doi.org\/10.1210\/er.2010-0013.","DOI":"10.1210\/er.2010-0013"},{"key":"10.1016\/j.bmcl.2026.130792_bb0030","doi-asserted-by":"crossref","unstructured":"Fizazi K, Bernard-Tessier A, Roubaud G, et al. Targeted inhibition of CYP11A1 in castration-resistant prostate cancer. NEJM Evid 2024\/01\/01; 3(1):EVIDoa2300171. doi:https:\/\/doi.org\/10.1056\/EVIDoa2300171.","DOI":"10.1056\/EVIDoa2300171"},{"key":"10.1016\/j.bmcl.2026.130792_bb0035","doi-asserted-by":"crossref","unstructured":"Karimaa M, Riikonen R, Kettunen H, et al. First-in-class small molecule to inhibit CYP11A1 and steroid hormone biosynthesis. Mol Cancer Ther 2022\/12\/02; 21(12):1765-1776. doi:https:\/\/doi.org\/10.1158\/1535-7163.MCT-22-0115.","DOI":"10.1158\/1535-7163.MCT-22-0115"},{"key":"10.1016\/j.bmcl.2026.130792_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2026.130567","article-title":"Design, synthesis, and biological evaluation of cytochrome P450 CYP11A1 inhibitors","volume":"135","author":"Wang","year":"2026","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2026.130792_bb0040","doi-asserted-by":"crossref","unstructured":"Strushkevich N, MacKenzie F, Cherkesova T, et al. Structural basis for pregnenolone biosynthesis by the mitochondrial monooxygenase system. Proc Natl Acad Sci U S A 2011\/06\/21; 108(28):10139-10143. doi:https:\/\/doi.org\/10.1073\/pnas.1019441108.","DOI":"10.1073\/pnas.1019441108"},{"key":"10.1016\/j.bmcl.2026.130792_bb0065","doi-asserted-by":"crossref","unstructured":"Peng Y, Wu H, Zhang X, et al. A comprehensive assay for nine major cytochrome P450 enzymes activities with 16 probe reactions on human liver microsomes by a single LC\/MS\/MS run to support reliable in vitro inhibitory drug\u2013drug interaction evaluation. Xenobiotica 2015\/11; 45(11):961-977. doi:https:\/\/doi.org\/10.3109\/00498284.2015.1036954.","DOI":"10.3109\/00498254.2015.1036954"},{"key":"10.1016\/j.bmcl.2026.130792_bb0070","doi-asserted-by":"crossref","unstructured":"Wang JJ, Guo JJ, Zhan J, Bu HZ, Lin JH. An in-vitro cocktail assay for assessing compound mediated inhibition of six major cytochrome P450 enzymes. J Pharm Anal 2014\/08; 4(4):270-278. doi:https:\/\/doi.org\/10.1016\/j.jpha.2014.01.001.","DOI":"10.1016\/j.jpha.2014.01.001"},{"key":"10.1016\/j.bmcl.2026.130792_bb0075","doi-asserted-by":"crossref","unstructured":"Yao M, Zhu M, Sinz MW, Zhang H, Humphreys WG, Rodrigues AD, Dai R. Development and full validation of six inhibition assays for five major cytochrome P450 enzymes in human liver microsomes using an automated 96-well microplate incubation format and LC-MS\/MS analysis. J Pharm Biomed Anal 2007\/06; 44(1):211-223. doi:https:\/\/doi.org\/10.1016\/j.jpba.2007.02.034.","DOI":"10.1016\/j.jpba.2007.02.034"},{"key":"10.1016\/j.bmcl.2026.130792_bb0050","author":"International Council for Harmonisation of tTechnical rRequirements for Pharmaceuticals for Human uUse"},{"key":"10.1016\/j.bmcl.2026.130792_bb0055","doi-asserted-by":"crossref","unstructured":"Guengerich FP. Cytochrome P450 and chemical toxicology. Chem Res Toxicol 2008\/01; 21(1):70-83. doi:https:\/\/doi.org\/10.1021\/tx700079z.","DOI":"10.1021\/tx700079z"},{"key":"10.1016\/j.bmcl.2026.130792_bb0060","doi-asserted-by":"crossref","unstructured":"Khojasteh SC, Prabhu S, Kenny JR, Halladay JS, Lu AYH. Chemical inhibitors of cytochrome P450 isoforms in human liver microsomes: a re-evaluation of P450 isoform selectivity. Eur J Drug Metab Pharmacokinet 2011\/03; 36(1):1-16. doi:https:\/\/doi.org\/10.1007\/s13318-011-0024-2.","DOI":"10.1007\/s13318-011-0024-2"},{"key":"10.1016\/j.bmcl.2026.130792_bb0080","doi-asserted-by":"crossref","unstructured":"Salsali M, Holt A, Baker GB. Inhibitory effects of the monoamine oxidase inhibitor tranylcypromine on the cytochrome P450 enzymes CYP2C19, CYP2C9, and CYP2D6. Cell Mol Neurobiol 2004\/02; 24(1):63-76. doi:https:\/\/doi.org\/10.1023\/B:CEMN.0000012728.31108.4a.","DOI":"10.1023\/B:CEMN.0000012725.31108.4a"},{"key":"10.1016\/j.bmcl.2026.130792_bb0045","author":"U.S. Food and Drug Administration"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X26002593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X26002593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:28:46Z","timestamp":1792081726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X26002593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,2]]},"references-count":17,"alternative-id":["S0960894X26002593"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130792","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2027,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and biological evaluation of 4H-pyran-4-one-based CYP11A1 inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130792","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130792"}}